Bills · S 3762
IN COMMITTEE· 119TH CONGRESS
Senate BillS 3762Health
Prior Authorization Relief Act
INTRO FEB 3· LAST ACTION FEB 3
READING
3MIN
COSPONSORS
1
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenVoters should care about this bill because it addresses a common frustration: the delays and administrative hurdles associated with "prior authorization" in healthcare. Many people experience situations where their doctor recommends a treatment or drug, but their insurance plan requires them to get permission first, often leading to long waits, appeals, and sometimes denial of care. If this bill becomes law, it could lead to quicker access to certain high-cost, evidence-backed medical services and drugs for people in Medicare Advantage, as the approval process would be simplified and more consistent across plans.
Without this bill, the current varied and often complex prior authorization requirements across different Medicare Advantage plans would continue, potentially causing ongoing delays, administrative burden for both patients and providers, and uncertainty about getting necessary care. By standardizing these processes and offering exemptions to providers in certain value-based care models, the bill seeks to balance cost control with timely access to medically necessary treatments, making the healthcare system more efficient and patient-friendly in specific areas.
KEY PROVISIONS
4AI-extractedPROVISION 01
Requires the Secretary of Health and Human Services to audit prior authorization requirements for high-cost medical services and Part D drugs that have clear clinical evidence but currently involve too many approval steps.
This ensures the reforms target the most problematic and frequently used prior authorization processes, maximizing their impact on patient access and administrative burden.
PROVISION 02
Directs the Secretary to create a final rule by May 1, 2028, to standardize prior authorization requirements for the identified services and drugs across all Medicare Advantage plans.
This would reduce confusion and inconsistency, making it easier for both patients and providers to navigate the approval process, potentially speeding up care delivery.
PROVISION 03
Exempts healthcare providers participating in certain "two-sided risk" payment models (like some Accountable Care Organizations) from prior authorization for these standardized services and drugs.
This provision incentivizes providers to take on financial responsibility for patient outcomes by removing a significant administrative hurdle, potentially promoting more efficient and coordinated care.
PROVISION 04
Allows Medicare Advantage organizations to request that the prior authorization exemption for two-sided risk providers not apply to their plans, meaning prior authorizations would still be required.
This provides flexibility for Medicare Advantage plans to maintain some level of utilization management if they deem it necessary, adding a layer of control for the insurers.
SPONSORSHIP
1 + 1
D· Rhode Island
YRS IN OFFICE
19
BILLS LED
100
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 0 REP 1 IND 0
ACTION TIMELINE
2 EVENTSFEB 3
Introduced in Senate
FEB 3
Read twice and referred to the Committee on Finance.
BILL INFO
TypeSenate Bill
NumberS 3762
Congress119th
StatusIn Committee
IntroducedFeb 3, 2026
Last actionFeb 3, 2026
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · FINANCE COMMITTEE · INTRODUCED FEB 3, 2026
Senate BillS 3762Health
Prior Authorization Relief Act
INTRODUCED FEB 3, 2026· LAST ACTION FEB 3, 2026
PASSAGE CHANCES
—%
READING
3 min
COSPONSORS
1
COMPLEXITY
Moderate
